{
    "organizations": [],
    "uuid": "fac27e20b7741c2592b729cf0554be3e57b49297",
    "author": "",
    "url": "https://www.reuters.com/article/brief-medicines360-and-allergan-present/brief-medicines360-and-allergan-present-5-year-trial-data-from-on-going-ius-clinical-study-idUSASC09Y7C",
    "ord_in_thread": 0,
    "title": "BRIEF-Medicines360 And Allergan Present 5-Year Trial Data From On-Going IUS Clinical Study",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 30, 2018 / 12:50 PM / in 6 minutes BRIEF-Medicines360 And Allergan Present 5-Year Trial Data From On-Going IUS Clinical Study Reuters Staff 1 Min Read\nApril 30 (Reuters) - Allergan plc:\n* MEDICINES360 AND ALLERGAN PRESENT 5-YEAR TRIAL DATA FROM LARGEST ON-GOING IUS CLINICAL STUDY Source text for Eikon: Further company coverage:",
    "published": "2018-04-30T15:47:00.000+03:00",
    "crawled": "2018-04-30T16:02:53.050+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "pm",
        "minute",
        "allergan",
        "present",
        "trial",
        "data",
        "ius",
        "clinical",
        "study",
        "reuters",
        "staff",
        "min",
        "read",
        "april",
        "reuters",
        "allergan",
        "plc",
        "medicines360",
        "allergan",
        "present",
        "trial",
        "data",
        "largest",
        "ius",
        "clinical",
        "study",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}